glp 1 london New research identifies a mechanism of action for the GLP-1 receptor, the target of GLP-1 diabetes drugs | Imperial News Weight Loss Injections London Bridge

There are multiple amylins in phase II trials, including Amycretin (another dual amylin/GLP-1 agonist, Novo Nordisk) and Eloralintide (a single-target amylin analogue, Eli Lilly)

The common and reported Wegovy side effects include nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and runny nose, or sore throat

Biochemical and Biophysical Research Communications, 506 (4), 976982

Leptin, another adipokine, is not a confirmed substrate for DPP-4 like adiponectin but may have a putative DPP-4 truncation site [99]

For weight management (Zepbound), coverage is less common, though it is expanding

Prioritize protein Weight loss always includes some muscle loss, but ensuring adequate protein intake helps minimize it